Mouse anaphylactic shock is caused by reduced cardiac output, but not by systemic vasodilatation or pulmonary vasoconstriction, via PAF and histamine

Life Sciences

Volumn 116, Issue 2, 2014, Pages 98-105

  Wang, Mofei ^a,b   Shibamoto, Toshishige ^a   Tanida, Mamoru ^a   Kuda, Yuhichi ^a   Kurata, Yasutaka ^a  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

^b CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Anaphylaxis; Pulmonary arterial pressure; Pulmonary vascular resistance; Total peripheral resistance

Indexed keywords

2 [N (2 METHOXY 3 OCTADECYLCARBAMOYLOXYPROPOXYCARBONYL)ACETAMIDOMETHYL] 1 ETHYLPYRIDINIUM CHLORIDE; DIPHENHYDRAMINE; HISTAMINE; KETANSERIN; LEUKOTRIENE C4; MONTELUKAST; OVALBUMIN; SEROTONIN; THROMBOCYTE ACTIVATING FACTOR; FIBRINOGEN RECEPTOR; G PROTEIN COUPLED RECEPTOR; PYRIDINIUM DERIVATIVE; THROMBOCYTE ACTIVATING FACTOR RECEPTOR;

ANAPHYLACTIC HYPOTENSION; ANAPHYLACTIC SHOCK; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA FLOW; ARTICLE; ARTIFICIAL VENTILATION; BLOOD VESSEL REACTIVITY; CENTRAL VENOUS PRESSURE; CONTROLLED STUDY; EXPERIMENTAL HYPOTENSION; EXPERIMENTAL SYSTEMIC ANAPHYLAXIS; HEART LEFT ATRIUM PRESSURE; HEART OUTPUT; HYPOTENSION; LUNG ARTERY PRESSURE; LUNG BLOOD VESSEL; LUNG VASCULAR RESISTANCE; LUNG VASOCONSTRICTION; MALE; MEAN ARTERIAL PRESSURE; MOUSE; NONHUMAN; SENSITIZATION; VASCULAR RESISTANCE; VASODILATATION; ANAPHYLAXIS; ANIMAL; ARTERIAL PRESSURE; BAGG ALBINO MOUSE; HEMODYNAMICS; IMMUNOLOGY; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; VASOCONSTRICTION;

ANAPHYLAXIS; ANIMALS; ARTERIAL PRESSURE; CARDIAC OUTPUT; DIPHENHYDRAMINE; HEMODYNAMICS; HISTAMINE; HYPOTENSION; MALE; MICE; MICE, INBRED BALB C; OVALBUMIN; PLATELET ACTIVATING FACTOR; PLATELET MEMBRANE GLYCOPROTEINS; PYRIDINIUM COMPOUNDS; RECEPTORS, G-PROTEIN-COUPLED; VASCULAR RESISTANCE; VASOCONSTRICTION; VASODILATION;

EID: 84908011239     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2014.09.010     Document Type: Article

References (43)

1. F.G. AI-Amran, N.R. Hadi, and A.M. Hashim Cysteinyl leukotriene receptor antagonist montelukast ameliorates acute lung injury following haemorrhagic shock in rats Eur J Cardiothorac Surg 43 2013 421 427
2. A.F.T. Brown Anaphylactic shock: mechanism and treatment J Accid Emerg Med 12 1995 89 100
3. S.G. Brown Cardiovascular aspects of anaphylaxis: implications for treatment and diagnosis Curr Opin Allergy Clin Immunol 5 2005 359 364
4. A. Celik, E. Ergun, N. Koksal, A.S. Celik, E. Altinli, and M.A. Uzun Effects of montelukast on the healing of ischemic colon anastomoses Am J Surg 206 2013 502 508
5. C. Chrusch, S. Sharma, H. Unruh, E. Bautista, K. Duke, and A. Becker Histamine H3 receptor blockade improves cardiac function in canine anaphylaxis Am J Respir Crit Care Med 160 1999 1142 1149
6. O.H. Cingolani, and D.A. Kass Pressure-volume relation analysis of mouse ventricular function Am J Physiol Heart Circ Physiol 301 2011 H2198 H2206
7. S. Cui, T. Shibamoto, W. Zhang, H. Takano, and Y. Kurata Venous resistance increases during rat anaphylactic shock Shock 29 2008 733 739
8. H. Cui, Y. Okamoto, K. Yoshioka, W. Du, N. Takuwa, and W. Zhang Sphingosine-1-phosphate receptor 2 protects against anaphylactic shock through suppression of endothelial nitric oxide synthase in mice J Allergy Clin Immunol 132 2013 1205 1214
9. N.R. Fahmy Hemodynamics, plasma histamine and catecholamine concentrations during an anaphylactoid reaction to morphine Anesthesiology 55 1981 329 331
10. S.B. Felix, G. Baumann, and W.E. Berdel Systemic anaphylaxis - separation of cardiac reactions from respiratory and peripheral vascular events Res Exp Med (Berlin) 190 1990 239 252
11. S.B. Felix, G. Baumann, M. Niemczyk, T. Hashemi, G. Ochsenfeld, and Z. Ahmad Effects of histamine H1- and H2-receptor antagonists on cardiovascular function during systemic anaphylaxis in guinea pigs Agents Actions 32 1991 245 252
12. M. Fisher Clinical observations on the pathophysiology and treatment of anaphylactic cardiovascular collapse Anaesth Intensive Care 14 1986 17 21
13. M. Halonen, H.K. Fisher, C. Blair, C. Butler 2nd, and R.N. Pinckard IgE-induced respiratory and circulatory changes during systemic anaphylaxis in the rabbit Am Rev Respir Dis 114 1976 961 970
14. P.K. Hanashiro, and M.H. Weil Anaphylactic shock in Man. Report of two cases with detailed hemodynamic and metabolic studies Arch Intern Med 119 1967 129 140
15. 2 on cardiac contractility: a negative inotropism secondary to coronary vasoconstriction conceals a primary positive inotropic action J Pharmacol Exp Ther 237 1986 719 724
16. J. Jacobsen, C.R. Johnsen, P.S. Skov, J. Warberg, U. Knigge, and N.H. Secher Cardiovascular and hormonal responses to anaphylactic shock in the pig Clin Physiol 15 1995 81 90
17. M. Karmazyn, and M.P. Moffat Positive inotropic effects of low concentrations of leukotrienes C4 and D4 in rat heart Am J Physiol 259 1990 H1239 H1246
18. N.G. Kounis, G.D. Soufras, and G. Hahalis Anaphylactic shock: Kounis hypersensitivity-associated syndrome seems to be the primary cause N Am J Med Sci 5 2013 631 636
19. Y. Kuda, Y. Kurata, M. Wang, M. Tanida, and T. Shibamoto Major contribution of vasospasm-induced coronary blood flow reduction to anaphylactic ventricular dysfunction assessed in isolated blood-perfused rat heart Cardiol J 21 2014 11 17
20. S. Läer, F. Remmers, H. Scholz, B. Stein, F.U. Müller, and J. Neumann Receptor mechanisms involved in the 5-HT-induced inotropic action in the rat isolated atrium Br J Pharmacol 123 1998 1182 1188
21. W. Leng, K. Chang, J.R. Williamson, and B.A. Jakschik Increased regional vascular albumin permeation in the rat during anaphylaxis J Immunol 142 1985 1982 1985
22. R. Levi, S.S. Gross, B. Lamparter, O.A. Fasehun, K. Aisaka, and E.A. Jaffe Evidence that l-arginine is the biosynthetic precursor of vascular and cardiac nitric oxide S. Moncada, E.A. Higgs, Nitric oxide from l-arginine: a bioregulatory system 1990 35 45 [Amsterdam, Netherlands]
23. J.H. Levy Anaphylactic/anaphylactoid reactions during cardiac surgery J Clin Anesth 1 1989 426 430
24. P.Y. Liu, C.H. Lee, L.J. Lin, and J.H. Chen Refractory anaphylactic shock associated with ketoconazole treatment Ann Pharmacother 39 2005 547 550
25. W. Liu, H. Takano, T. Shibamoto, S. Cui, Z.S. Zhao, and W. Zhang Involvement of splanchnic vascular bed in anaphylactic hypotension in anesthetized BALB/c mice Am J Physiol Regul Integr Comp Physiol 293 2007 R1947 R1953
26. S.N. Mink, A. Becker, H. Unruh, and W. Kepron Effects of anaphylaxis mediators on partitioned pulmonary vascular resistance during ragweed shock in dogs J Appl Physiol 84 1998 782 790
27. 2, and prostaglandins during systemic anaphylaxis in sheep Am J Physiol 261 1991 H782 H792
28. J. Moss, N.R. Fahmy, N. Sunder, and M.A. Beaven Hormonal and hemodynamic profile of an anaphylactic reaction in man Circulation 63 1981 210 213
29. R.L. Muelleman, M. Gatz, J.A. Salomone 3rd, B. Herndon, and G.A. Salzman Hemodynamic and respiratory effects of thyrotropin-releasing hormone and epinephrine in anaphylactic shock Ann Emerg Med 18 1989 534 541
30. R.F. Raper, and M.M. Fisher Profound reversible myocardial depression after anaphylaxis Lancet 1 1988 386 388
31. T. Shibamoto, S. Cui, Z. Ruan, W. Liu, H. Takano, and Y. Kurata Hepatic venoconstriction is involved in anaphylactic hypotension in rats Am J Physiol Heart Circ Physiol 289 2005 H1436 H1441
32. T. Shibamoto, W. Liu, S. Cui, W. Zhang, H. Takano, and Y. Kurata PAF, rather than histamine, participates in mouse anaphylactic hypotension Pharmacology 82 2008 114 120
33. 2-adrenoceptor activation attenuate pulmonary vasoconstriction during anaphylactic hypotension in anesthetized BALB/c mice Exp Lung Res 39 2013 119 129
34. H.J. Silverman, C. Van Hook, and E.F. Haponik Hemodynamic changes in human anaphylaxis Am J Med 77 1984 341 344
35. H.J. Silverman, W.R. Taylor, P.L. Smith, A. Kagey-Sobotka, L.M. Lichtenstein, and E.R. Bleecker Prevention of canine anaphylaxis with isoproterenol Am Rev Respir Dis 134 1986 243 247
36. H.J. Silverman, W.R. Taylor, P.L. Smith, A. Kagey-Sobotka, S. Permutt, and L.M. Lichtenstein Effects of antihistamines on the cardiopulmonary changes due to canine anaphylaxis J Appl Physiol 64 1988 210 217
37. G. Smedegård, B. Revenäs, C. Lundberg, and K.E. Arfors Anaphylactic shock in monkeys passively sensitized with human reaginic serum. I. Hemodynamics and cardiac performance Acta Physiol Scand 111 1981 239 247
38. S. Sun, M.H. Weil, W. Tang, R.J. Gazmuri, J. Bisera, and S.R. Greenberg Cardiac anaphylaxis in the Sprague-Dawley rat J Lab Clin Med 120 1992 589 596
39. H. Tanaka, K. Nishimaru, M. Kobayashi, T. Matsuda, Y. Tanaka, and K. Shigenobu Acetylcholine-induced positive inotropy mediated by prostaglandin released from endocardial endothelium in mouse left atrium Naunyn Schmiedebergs Arch Pharmacol 363 2001 577 582
40. E.M. Wagner, W.A. Mitzner, and E.R. Bleecker Peripheral circulatory alterations in canine anaphylactic shock Am J Physiol Heart Circ Physiol 251 1986 H934 H940
41. J.B. West, C.T. Dollery, and A. Naimark Distribution of blood flow in isolated lung; relation to vascular and alveolar pressures J Appl Physiol 19 1964 713 724
42. H. Zaizen, S. Imanishi, M. Nasu, and M. Arita Diverse inotropic effects of 5-hydroxytryptamine in heart muscles of various mammalian species Heart Vessels 11 1996 10 17
43. 2-adrenoceptor activation by endogenous epinephrine in anesthetized rats Anesthesiology 114 2011 614 623